Aripiprazole-Sertraline Combination

The ASCEnD medication guide suggests maximum doses of aripiprazole 10 mg/day and sertraline 150 mg/day. Aripiprazole was selected because its pharmacological profile may improve antidepressant response while reducing manic switch risk. Low-dose aripiprazole may amplify response to sertraline through dopamine and serotonin modulation. Sertraline was chosen for safety, pharmacokinetics, limited psychotropic interactions, tolerability, and lack of cardiac arrhythmia risk. Lower-dose aripiprazole use is associated with symptom reduction and may reduce akathisia risk.